Cannara Biotech Inc. LOVE.V Stock
Cannara Biotech Inc. Price Chart
Cannara Biotech Inc. LOVE.V Financial and Trading Overview
| Cannara Biotech Inc. stock price | 0.91 CAD |
| Previous Close | 0.98 CAD |
| Open | 0.98 CAD |
| Bid | 0.91 CAD x N/A |
| Ask | 0.98 CAD x N/A |
| Day's Range | 0.91 - 0.98 CAD |
| 52 Week Range | 0.6 - 1.35 CAD |
| Volume | 55.1K CAD |
| Avg. Volume | 11.85K CAD |
| Market Cap | 82.43M CAD |
| Beta (5Y Monthly) | 1.28892 |
| PE Ratio (TTM) | 8.272728 |
| EPS (TTM) | 0.1 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LOVE.V Valuation Measures
| Enterprise Value | 128M CAD |
| Trailing P/E | 8.272728 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.8236634 |
| Price/Book (mrq) | 1.1489899 |
| Enterprise Value/Revenue | 2.832 |
| Enterprise Value/EBITDA | 11.219 |
Trading Information
Cannara Biotech Inc. Stock Price History
| Beta (5Y Monthly) | 1.28892 |
| 52-Week Change | -8.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.35 CAD |
| 52 Week Low | 0.6 CAD |
| 50-Day Moving Average | 0.88 CAD |
| 200-Day Moving Average | 0.97 CAD |
LOVE.V Share Statistics
| Avg. Volume (3 month) | 11.85K CAD |
| Avg. Daily Volume (10-Days) | 17.42K CAD |
| Shares Outstanding | 90.59M |
| Float | 67.63M |
| Short Ratio | 1.9 |
| % Held by Insiders | 45.57% |
| % Held by Institutions | 0% |
| Shares Short | 28.67K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.029% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 7.44% |
| Operating Margin (ttm) | 15.47% |
| Gross Margin | 45.99% |
| EBITDA Margin | 25.24% |
Management Effectiveness
| Return on Assets (ttm) | 3.78% |
| Return on Equity (ttm) | 5.01% |
Income Statement
| Revenue (ttm) | 45.2M CAD |
| Revenue Per Share (ttm) | 0.51 CAD |
| Quarterly Revenue Growth (yoy) | 75.59% |
| Gross Profit (ttm) | 17.33M CAD |
| EBITDA | 11.41M CAD |
| Net Income Avi to Common (ttm) | 3.37M CAD |
| Diluted EPS (ttm) | 0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.14M CAD |
| Total Cash Per Share (mrq) | 0.05 CAD |
| Total Debt (mrq) | 43.36M CAD |
| Total Debt/Equity (mrq) | 60.42 CAD |
| Current Ratio (mrq) | 2.681 |
| Book Value Per Share (mrq) | 0.792 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4805442 CAD |
| Levered Free Cash Flow (ttm) | -21060772 CAD |
Profile of Cannara Biotech Inc.
| Country | Canada |
| State | QC |
| City | Saint-Laurent |
| Address | 333 Decarie Blvd. |
| ZIP | H4N 3M9 |
| Phone | N/A |
| Website | https://cannara.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 270 |
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Q&A For Cannara Biotech Inc. Stock
What is a current LOVE.V stock price?
Cannara Biotech Inc. LOVE.V stock price today per share is 0.91 CAD.
How to purchase Cannara Biotech Inc. stock?
You can buy LOVE.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cannara Biotech Inc.?
The stock symbol or ticker of Cannara Biotech Inc. is LOVE.V.
Which industry does the Cannara Biotech Inc. company belong to?
The Cannara Biotech Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Cannara Biotech Inc. have in circulation?
The max supply of Cannara Biotech Inc. shares is 90.02M.
What is Cannara Biotech Inc. Price to Earnings Ratio (PE Ratio)?
Cannara Biotech Inc. PE Ratio is 9.10000000 now.
What was Cannara Biotech Inc. earnings per share over the trailing 12 months (TTM)?
Cannara Biotech Inc. EPS is 0.1 CAD over the trailing 12 months.
Which sector does the Cannara Biotech Inc. company belong to?
The Cannara Biotech Inc. sector is Healthcare.